Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 21;12(8):e9917.
doi: 10.7759/cureus.9917.

Safety and Efficacy of Stem Cell Therapy in Patients With Ischemic Stroke

Jeevan Gautam  1 , Amer Alaref  2   3   4   5 , Abdallah Hassan  6 , Rajan Sharma Kandel  6 , Rohi Mishra  6 , Nusrat Jahan  6
Affiliations
Review

Safety and Efficacy of Stem Cell Therapy in Patients With Ischemic Stroke

Jeevan Gautam et al. Cureus. .

Abstract

Stem cell therapy is emerging as a promising treatment strategy to treat patients with stroke. While there are established modes of treatment for stroke patients such as thrombolysis and endovascular intervention, most of the stroke patients frequently end up with major residual deficits or even death. The use of stem cells to treat stroke has been found to be beneficial in the animal models but strict evidence for the same in humans is still lacking. We reviewed 13 clinical trials of stem cell therapy in stroke patients conducted between 2014 and 2020 based on the search using the database PubMed, and the clinical trial registry (www.clinicaltrials.gov). We aimed to assess the safety and efficacy of stem cell treatment in stroke patients who participated in the trials. Quality assessment of the clinical trials revealed a sub-optimal score. We found mixed results regarding the efficacy of stem cells in the treatment of ischemic stroke although we could not do a quantitative analysis of the effect outcomes. Assessment for safety revealed promising results as there were only minor side effects related to cell therapy. Although stem cell therapy seems to be a promising strategy to treat stroke patients in the future, we concluded that the field needs more evidence regarding the safety and efficacy of the use of stem cells in stroke patients before we use them in the clinic.

Keywords: clinical trials; ischemic stroke; stem cell therapy; stem cells; stroke treatment.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Selection process
See this image and copyright information in PMC

References

    1. GBD 2016 Stroke Collaborators. 2016. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the global burden of disease study. - PMC - PubMed
    1. Stroke in the 21st century: a snapshot of the burden, epidemiology, and quality of life. Donkor ES. Stroke Res Treat. 2018;2018:3238165. - PMC - PubMed
    1. Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Benjamin EJ, Muntner P, Alonso A, et al. Circulation. 2019;139:0. - PubMed
    1. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Circulation. 2007;115:0. - PubMed
    1. Mesenchymal stem cell therapy in stroke: a systematic review of literature in pre-clinical and clinical research. Zheng H, Zhang B, Chhatbar PY, et al. Cell Transplant. 2018;27:1723–1730. - PMC - PubMed

LinkOut - more resources